Similar articles

• Synthesis and anticonvulsant activity of some new pyrazolo[3,4-b]pyrazines and related heterocycles.

  Farghaly AR, Esmail S, Abdel-Zaher A, Abdel-Hafez A, El-Kashef H. Farghaly AR, et al. Bioorg Med Chem. 2014 Apr 1;22(7):2166-75. doi: 10.1016/j.bmc.2014.02.019. Epub 2014 Feb 25. Bioorg Med Chem. 2014. PMID: 24618512
• Targeted Degradation of the Oncogenic Phosphatase SHP2.

  Vemulapalli V, Donovan KA, Seegar TCM, Rogers JM, Bae M, Lumpkin RJ, Cao R, Henke MT, Ray SS, Fischer ES, Cuny GD, Blacklow SC. Vemulapalli V, et al. Biochemistry. 2021 Aug 31;60(34):2593-2609. doi: 10.1021/acs.biochem.1c00377. Epub 2021 Aug 19. Biochemistry. 2021. PMID: 34411482 Free PMC article.
• New pyrazolo[3,4-b]pyrazines: synthesis and biological activity.

  el-Kashef HS, el-Emary TI, Gasquet M, Timon-David P, Maldonado J, Vanelle P. el-Kashef HS, et al. Pharmazie. 2000 Aug;55(8):572-6. doi: 10.1002/chin.200047151. Pharmazie. 2000. PMID: 10989833
• Strategies Targeting Protein Tyrosine Phosphatase SHP2 for Cancer Therapy.

  Song Y, Wang S, Zhao M, Yang X, Yu B. Song Y, et al. J Med Chem. 2022 Feb 24;65(4):3066-3079. doi: 10.1021/acs.jmedchem.1c02008. Epub 2022 Feb 14. J Med Chem. 2022. PMID: 35157464 Review.
• Allosteric Inhibitors of SHP2: An Updated Patent Review (2015-2020).

  Wu J, Zhang H, Zhao G, Wang R. Wu J, et al. Curr Med Chem. 2021;28(19):3825-3842. doi: 10.2174/1568011817666200928114851. Curr Med Chem. 2021. PMID: 32988341 Review.